How big is the low temperature sterilization market?

The global low temperature sterilization market size was estimated at USD 2.74 billion in 2024 and is expected to reach USD 3.00 billion in 2025.

What is the low temperature sterilization market growth?

The global low temperature sterilization market is expected to grow at a compound annual growth rate of 10.99% from 2025 to 2030 to reach USD 5.07 billion by 2030.

Which segment accounted for the largest low temperature sterilization market share?

North America dominated the low temperature sterilization market with a share of 34.81% in 2024. This is attributable to the increasing demand for minimally invasive surgeries, which rely on highly sensitive instruments unsuitable for traditional high-temperature sterilization methods. This has elevated the need for low temperature sterilization technologies, which are gentler on delicate instruments. Technological advancements, including vaporized hydrogen peroxide, ozone, and nitrogen dioxide sterilization methods, enhance efficiency and reduce cycle times, making them more attractive to healthcare providers focused on increasing patient throughput.

Who are the key players in low temperature sterilization market?

Some key players operating in the low temperature sterilization market include ASP Global (Fortive Corporation), Getinge, STERIS, Stryker, TDK Corporation, 3M, Steelco S.p.A., Bionics Scientific (a Unit of Kartal Projects Pvt Ltd.), DE LAMA S.P.A., Genist Technocracy Pvt. Ltd., Andersen Sterilizers, Labotronics Scientific, Labtron Equipment Ltd, Qingdao Antech Scientific Co., Ltd., Renosem, Scitek Global Co., Ltd., SOLSTEO, Sterile Safequip And Chemicals LLP, Tuttnauer, HUMAN MEDITEK CO., LTD., MMM Group, Canon Singapore Pte. Ltd., INSTECH SYSTEMS, Biobase Biodusty (Shandong), Co., Ltd., Telstar (Azbil Group), Shinva Medical Instrument Co., Ltd.

What are the factors driving the low temperature sterilization market?

Key factors that are driving the market growth include developments in medical devices, increasing investment in sterilization devices and infrastructure, and expansion into emerging economies.